Literature DB >> 3894348

The Escherichia coli O6-methylguanine-DNA methyltransferase does not repair promutagenic O6-methylguanine residues when present in Z-DNA.

S Boiteux, R Costa de Oliveira, J Laval.   

Abstract

The repair of O6-methylguanine present in N-methylnitrosourea (MNU)-treated alternating polynucleotides MNU-poly(dG-dC) X poly(dG-dC) and MNU-poly(dG-me5dC) X poly(dG-me5dC] was investigated using O6-methylguanine-DNA methyltransferase purified from Escherichia coli. Both modified polynucleotides are equally good substrates for the DNA methyltransferase when they are in the B-form. The substrate properties of the MNU-treated polynucleotides do not differ from those of MNU-treated DNA. One of these modified polynucleotides, MNU-poly(dG-me5dC) X (dG-me5dC), can adopt the Z-conformation under physiological conditions. The conformational transition of the poly(dG-me5dC) X poly(dG-me5dC) from the B-form to the Z-form was monitored by the modification of its spectroscopic properties and by the specific binding of antibodies raised against Z-DNA. The O6-methylguanine residues are repaired in MNU-poly(dG-me5dC) X poly(dG-me5dC) in B-form. At variance, the conversion of this template to the Z-form completely inhibits the repair of the O6-methylguanine residues. The cooperative transition from the Z- to the B-form of MNU-poly(dG-me5dC) X poly(dG-me5dC), mediated by intercalating drugs such as ethidium bromide, restores the ability of MNU-poly(dG-me5dC) X poly(dG-me5dC) to be substrate for the transferase. These results imply that the promutagenic DNA lesion O6-methylguanine persists in Z-DNA fragments and suggest that DNA conformation modulates the extent of DNA repair and, as a result, plays an important role in determining the mutagenic potency of chemical carcinogens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894348

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Evolutionary consequences of nonrandom damage and repair of chromatin domains.

Authors:  T Boulikas
Journal:  J Mol Evol       Date:  1992-08       Impact factor: 2.395

Review 2.  Non-B DNA structure-induced genetic instability and evolution.

Authors:  Junhua Zhao; Albino Bacolla; Guliang Wang; Karen M Vasquez
Journal:  Cell Mol Life Sci       Date:  2009-09-01       Impact factor: 9.261

3.  Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats.

Authors:  J R Spitzner; I K Chung; M T Muller
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

Review 4.  Impact of alternative DNA structures on DNA damage, DNA repair, and genetic instability.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2014-04-21

Review 5.  Drug resistance and DNA repair.

Authors:  M Fox; J J Roberts
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Circular dichroism of poly(dG-dC) modified by the carcinogens N-methyl-4-aminoazobenzene or 4-aminobiphenyl.

Authors:  P A Abuaf; F F Kadlubar; D Grunberger
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

7.  Cleavage and binding of a DNA fragment containing a single 8-oxoguanine by wild type and mutant FPG proteins.

Authors:  B Castaing; A Geiger; H Seliger; P Nehls; J Laval; C Zelwer; S Boiteux
Journal:  Nucleic Acids Res       Date:  1993-06-25       Impact factor: 16.971

8.  Excision of cytosine hydrates from Z-DNA.

Authors:  N J Duker; K M Weems
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

9.  The ultimate carcinogen of 4-nitroquinoline 1-oxide does not react with Z-DNA and hyperreacts with B-Z junctions.

Authors:  C Rodolfo; A Lanza; S Tornaletti; G Fronza; A M Pedrini
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

Review 10.  Models for chromosomal replication-independent non-B DNA structure-induced genetic instability.

Authors:  Guliang Wang; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.